Sunday, 8 January 2023

Zydus Lifescience

 Zydus Lifescience has the USFDA approval for an insomnia drug, a generic version of Triazolam, to be manufactured at its Ahmedabad facility. A big positive.

India Daybook – Stocks in News

*P&G:* Net profit up 36.5% Rs 210.7 cr, Revenue up 8.9% at Rs 1,138.4 cr YoY  *TVS Motors:* Net profit at Rs 536.6 cr vs poll Rs 520.0 c...